Potential Resistant Mutations Within HBV Reverse Transcriptase Sequences in Nucleos(t)ide Analogues-Experienced Patients With Hepatitis B Virus Infection

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-44604-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Treatment of HBeAg-Negative Chronic Hepatitis B Patients With Nucleos(t)ide Analogues in Burkina Faso

Open Journal of Gastroenterology
2016English

Off-Treatment Efficacy of 3-Year Nucleos(t)ide Analogues in Chronic Hepatitis B Patients

Kaohsiung Journal of Medical Sciences
Medicine
2016English

Analysis of Resistant Mutations in Reverse Transcriptase Domain of Hepatitis B Virus From Patients From Islamabad, Pakistan

Journal of Unexplored Medical Data
2017English

Monitoring of Genotypic Resistance Profile in Chronic Hepatitis B Patients Receiving Nucleos(t)ide Analogues in Huzhou, China

Journal of Infection in Developing Countries
MedicineVirologyParasitologyInfectious DiseasesMicrobiology
2016English

Adherence to Nucleos(t)ide Analogues for Chronic Hepatitis B in Clinical Practice and Correlation With Virological Breakthroughs

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2011English

Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis B

Current Hepatitis Reports
2010English

Letter: Which Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma Should Receive Nucleos(t)ide Analogue Therapy? Authors' Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Telbivudine (Sebivo) in Patients With Hepatitis B Virus (HBV) Chronic Infection

Farmeconomia. Health economics and therapeutic pathways
2008English

Does Nucleos(t)ide Analogues Treatment Affect Renal Function in Chronic Hepatitis B Patients Who Have Already Decreased eGFR? A Longitudinal Study

PLoS ONE
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy